{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:10:41Z","timestamp":1787022641871,"version":"build-2736575974"},"reference-count":20,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Idiopathic intracranial hypertension (IIH) is a condition of increased intracranial pressure of unknown aetiology. Principal symptoms are headache, visual disturbances, and obesity, together with elevated intracranial pressure. Unspecified MRI, despite normal ventricle size, suggests alterations in the water flux cellular mediated by the brain water channel aquaporin-4 (AQP4). The association among IIH, cerebral spinal fluid malfunction, reabsorption, and functional or regulatory modifications of AQP4 is a hypothesis not confirmed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Blood samples were collected from 72 Spanish Caucasian patients with IIH. A genetic association study was performed with bi-allelic SNPs rs1049305 and rs10244884 in AQ1 and rs2075575, rs3763043, and rs3763040 in AQ4. Genetic data were compared with 94 healthy Caucasian control. Statistics studies were assessed by Pearson\u2019s\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      tests for 2 \u00d7 2 (alleles) or 3 \u00d7 2 (genotypes) contingency tables. A\n                      <jats:italic>P<\/jats:italic>\n                      value &lt; 0.05 was considered to be statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Statistically significant differences were found when comparing the results of the rs3763040 polymorphism of the AQ4 locus of IIH patients with controls, in genotypic frequencies (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0442) and allele frequencies (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0171). Furthermore, a statistically significant difference (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0207) was found in individuals carrying and not carrying the minor allele (GG + GA individuals vs GG homozygotes). No statistically significant differences were found when comparing allele and genotypic frequencies for SNPs rs1049305 and rs10244884 of AQ1 and rs2075575 and rs3763043 of AQ4.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The association of AQP4 and specifically of its polymorphic variant rs3763040 with IIH should be validated in other ethnic groups in order to assess more precisely the role of AQP4 in the etiopathogenesis of IIH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/tnsci-2022-0309","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T12:10:37Z","timestamp":1694434237000},"source":"Crossref","is-referenced-by-count":2,"title":["Association between RS3763040 polymorphism of the AQP4 and idiopathic intracranial hypertension in a Spanish Caucasian population"],"prefix":"10.1515","volume":"14","author":[{"given":"Juan Jos\u00e9","family":"Teller\u00eda-Orriols","sequence":"first","affiliation":[{"name":"Unit of Excellence Institute of Biology and Molecular Genetics (IBGM), University of Valladolid and Spanish National Research Council (CSIC) , Valladolid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samsara","family":"L\u00f3pez-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Medina del Campo Hospital , Medina del Campo , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Vidriales-Vicente","sequence":"additional","affiliation":[{"name":"Clinic Biochemistry, University Clinic Hospital of Valladolid , Valladolid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto","family":"Rodr\u00edguez-Arias","sequence":"additional","affiliation":[{"name":"University Clinic Hospital of Valladolid , Valladolid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"2023091116103046913_j_tnsci-2022-0309_ref_001","doi-asserted-by":"crossref","unstructured":"Dhungana S, Sharrack B, Woodroofe N. Idiopathic intracranial hypertension. Acta Neurol Scand. 2010;121:71\u201382.","DOI":"10.1111\/j.1600-0404.2009.01172.x"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_002","doi-asserted-by":"crossref","unstructured":"Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492\u20135.","DOI":"10.1212\/01.WNL.0000029570.69134.1B"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_003","doi-asserted-by":"crossref","unstructured":"Kanagalingam S, Subramanian PS. Update on idiopathic intracranial hypertension. Curr Treat Options Neurol. 2018;20(7):24.","DOI":"10.1007\/s11940-018-0512-7"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_004","doi-asserted-by":"crossref","unstructured":"Madriz G, Cestari DM. An update of idiopathic intracranial hypertension. Neuro-Ophthalmology. 2018;29:495\u2013502.","DOI":"10.1097\/ICU.0000000000000518"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_005","doi-asserted-by":"crossref","unstructured":"Barkatullah AF, Leishangthem L, Moss HE. MRI findings as markers of idiopathic intracranial hypertension. Curr Opin Neurol. 2021;34(1):75\u201383.","DOI":"10.1097\/WCO.0000000000000885"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_006","doi-asserted-by":"crossref","unstructured":"Holbrook J, Saindane AM. Imaging of intracranial pressure disorders. Neurosurgery. 2017;80(3):341\u201354.","DOI":"10.1227\/NEU.0000000000001362"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_007","doi-asserted-by":"crossref","unstructured":"Corbett JJ. The first Jacobson Lecture. Familial idiopathic intracranial hypertension. J Neuroophthalmol. 2008;28:337\u201347.","DOI":"10.1097\/WNO.0b013e31818f12a2"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_008","doi-asserted-by":"crossref","unstructured":"Qiao L, Wei Y. Familial idiopathic intracranial hypertension in two non-obese Chinese sisters. Front Neurol. 2020;11:569432.","DOI":"10.3389\/fneur.2020.569432"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_009","doi-asserted-by":"crossref","unstructured":"Behbehani R, Ali A, Al-Mousa AJ, Albuloushi SN. Familial non-obese idiopathic intracranial hypertension. Am J Ophthalmol Case Rep. 2022;27:101619.","DOI":"10.1016\/j.ajoc.2022.101619"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_010","unstructured":"Klein A, Dotan G, Kesler A. Familial Occurrence of Idiopathic Intracranial Hypertension. Isr Med Assoc J. 2018;Sep;20(9):557\u201360."},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_011","doi-asserted-by":"crossref","unstructured":"Tait MJ, Saadoun S, Bell BA, Papadopoulos MC. Water movements in the brain: role of aquaporins. Trends Neurosci. 2008;31(1):37\u201343.","DOI":"10.1016\/j.tins.2007.11.003"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_012","doi-asserted-by":"crossref","unstructured":"Dasdelen D, Mogulkoc R, Baltaci AK. Aquaporins and roles in brain health and brain injury. Mini Rev Med Chem. 2020;20(6):498\u2013512.","DOI":"10.2174\/1389557519666191018142007"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_013","doi-asserted-by":"crossref","unstructured":"Beri S, Chandratre S, Chow G. Familial idiopathic intracranial hypertension with variable phenotype. Eur J Paediatr Neurol. 2011;15(1):81\u20133.","DOI":"10.1016\/j.ejpn.2010.02.005"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_014","doi-asserted-by":"crossref","unstructured":"Papadopoulos MC, Manley GT, Krishna S, Verkman AS. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J. 2004;18:1291\u20133.","DOI":"10.1096\/fj.04-1723fje"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_015","doi-asserted-by":"crossref","unstructured":"Tanimura Y, Hiroaki Y, Fujiyoshi Y. Acetazolamide reversibly inhibits water conduction by aquaporin-4. J Struct Biol. 2009;166(1):16\u201321.","DOI":"10.1016\/j.jsb.2008.11.010"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_016","doi-asserted-by":"crossref","unstructured":"Millichap JG, Millichap JJ. Mechanism of action of acetazolamide and idiopathic intracranial hypertension. Front Neurol. 2015 Feb 3;6:13.","DOI":"10.3389\/fneur.2015.00013"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_017","doi-asserted-by":"crossref","unstructured":"Wall M, McDermott M, Kupersmith M. Idiopathic intracranial hypertension \u2013 reply. JAMA. 2014;312:1060. 10.1001\/jama.2014.8903.","DOI":"10.1001\/jama.2014.8903"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_018","unstructured":"Qiu W, Chang Y, Li R, Long Y, Huang J, Mai W, et al. [Correlation of AQP4 gene polymorphism with NMO clinical phenotypes and its underlying mechanism]. Zhonghua Yi Xue Za Zhi. 2015;1795(7):501\u20136."},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_019","doi-asserted-by":"crossref","unstructured":"Burfeind KG, Murchison CF, Westaway SK, Simon MJ, Erten-Lyons D, Kaye JA, et al. The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2017 26;3(3):348\u201359.","DOI":"10.1016\/j.trci.2017.05.001"},{"key":"2023091116103046913_j_tnsci-2022-0309_ref_020","doi-asserted-by":"crossref","unstructured":"Kerty E, Heuser K, Indahl UG, Berg PR, Nakken S, Lien S, et al. Is the brain water channel aquaporin-4 a pathogenetic factor in idiopathic intracranial hypertension? Results from a combined clinical and genetic study in a Norwegian cohort. Acta Ophthalmol. 2013;91(1):88\u201391.","DOI":"10.1111\/j.1755-3768.2011.02231.x"}],"container-title":["Translational Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/tnsci-2022-0309\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/tnsci-2022-0309\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T12:10:45Z","timestamp":1694434245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/tnsci-2022-0309\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,9,11]]},"published-print":{"date-parts":[[2023,9,11]]}},"alternative-id":["10.1515\/tnsci-2022-0309"],"URL":"https:\/\/doi.org\/10.1515\/tnsci-2022-0309","relation":{},"ISSN":["2081-6936"],"issn-type":[{"value":"2081-6936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,1]]},"article-number":"20220309"}}